From Microbes to Metagenomes (April 1st, 2024): A Comparative Analysis of Sequencing Platforms for Metagenomic Applications

Uncertain about which sequencing platform is best for metagenomic applications? Allow us to guide you through the options. We’ve analyzed current sequencers, considering critical factors such as flow cell output and read length, sequencing duration, and cost. 

In this webinar, we present our analysis and field your questions. Don’t miss this opportunity to gain clarity and make well-informed decisions, regardless of whether you’re in a clinical or academic laboratory setting.


Dr. Mengchu Wu

Co-Founder and CEO of Micronbrane Medical

Mengchu is the Co-founder, CEO and Chairwoman of the Board of Micronbrane Medical.  She held executive positions at Health GeneTech, Personal Genomics and Vela Diagnostics after earning her Ph.D. in Biomedical Sciences at the UMass Chan School of Medicine.